Last reviewed · How we verify
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
The purpose of this pilot study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with myofascial trigger points.
Details
| Lead sponsor | ZARS Pharma Inc. |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 20 |
| Start date | 2010-06 |
| Completion | 2011-01 |
Conditions
- Myofascial Pain Syndromes
Interventions
- Heated lidocaine/tetracaine patch
Primary outcomes
- Pain intensity — Two weeks
Countries
United States